In the Abi Race study, response to abiraterone was greater and longer lasting in black men with prostate cancer, compared with white men.
Therapy with CAR T cells may benefit patients with highly refractory multiple myeloma, said U Penn’s Adam Cohen at ASCO 2018.
The use of geriatric assessment in routine care of older patients with advanced cancer may significantly improve doctor-patient communication.
A California study showed women are significantly undertreated for head and neck cancer, with several factors possibly accounting for the disparity.
Ribociclib plus endocrine therapy resulted in improved PFS in premenopausal women with HR+, HER2− advanced breast cancer.
Joshua Brody discusses ECHELON-1 and its subanalyses, the results of which are anticipated to change the management of Hodgkin lymphoma.
Alisa Domb highlighted training and workflow optimization for an ambulatory-setting navigation program covering 10 hem/onc clinics and 2 cancer centers, during the 2018 ONS Congress.
Medical oncologist Ryan J. Sullivan shared some interesting melanoma-related presentations from the 2018 ASCO Annual Meeting.
Updates to the 8th edition of AJCC's staging manual include incorporation of more nonanatomic features. Oncology Clinical Specialist Chelsea Backler discussed key changes during the 2018 ONS Congress.
Jeannine Brant, PhD, APRN-CNS, discussed the importance of using non-opioid modalities to manage cancer patients' pain, during the 2018 ONS Congress.